EMD Millipore Corp

EMD Millipore Corp, operating as Milliporesigma and doing business as EMD Millipore Corporation Division, manufactures and supplies laboratory water purification systems, filtration products, multiplex assay kits, and analytical instrumentation to federal agencies as a prime contractor on full-and-open competitive procurements with no set-aside posture. The company is a foreign-owned subsidiary of Merck KGaA, a Munich-headquartered parent entity, and competes across its federal footprint primarily on commercial merit and technical capability rather than through socioeconomic set-asides.

EMD Millipore's federal portfolio centers on concrete capability delivery: water purification and polishing systems (Milli-Q, Super Q, and proprietary designs); filtration and tangential-flow-filtration consumables; multiplex bead-based immunoassay kits (Luminex xMAP platforms and Milliplex assay panels); RT-PCR reagent kits; and maintenance, repair, and technical support services. Recent representative contracts illustrate the footprint. A $1.27 million firm fixed-price purchase order from the Department of Health and Human Services (awarded January 31, 2025) supplies gridded filters for the BioWatch biodefense program through December 2026. The Department of Veterans Affairs issued a $71.2 million five-year contract (September 2024, Veterans Integrated Service Network 20) for annual preventative maintenance of a Milli-Q water purification system at the Boise VA Medical Center. The U.S. Army DEVCOM Soldier Center at Aberdeen Proving Ground procured a Luminex xMAP INTELLIFLEX multiplex analysis system for $75,300 (September 2025). The Food and Drug Administration awarded a $1.27 million purchase order (January 2025) for BioWatch gridded filters, and a $72.6 million contract (September 2024) for Steritest sterility-testing systems to the FDA's New York laboratory. The USDA's Veterinary Services division procured three Luminex 200S systems for $128.8 thousand (July 2026) under a sole-source determination based on exclusive proprietorship of xMAP Salmonella serotyping technology.

Customer concentration is dispersed across 169 distinct federal agencies; the top five customer agencies by award count represent only 14 percent of awards, and the top five by potential value represent 11 percent of combined dollars. The Department of Health and Human Services Office of the Assistant Secretary for Administration leads by potential value ($20.1 million across 98 awards, primarily BioWatch program contracts), followed by the Army Medical Command ($5.4 million, 113 awards), the FDA ($2.7 million, 134 awards), the CDC Pittsburgh ($2.7 million, 98 awards), and the National Institute of Allergy and Infectious Diseases ($2.1 million, 103 awards). Despite this diffusion, the National Institutes of Health system (across NIH institutes and the Clinical Center) places the most individual task orders (218 awards to the Office of the Director alone), signaling strong volume concentration within the health research space even as dollar concentration remains flat.

EMD Millipore's vehicle position anchors to two primary indefinite delivery contracts. A Blanket Purchase Agreement with the National Institute of Mental Health (awarded February 22, 2024, running through February 28, 2027) carries no specified ceiling and authorizes procurement of laboratory supplies, biological materials, medical scientific equipment, and water purification supplies for use across the National Institutes of Health, CDC, Department of Defense, and FDA. A single-award Indefinite Delivery Contract with the USDA Grain Inspection, Packers and Stockyards Administration (awarded August 4, 2022, ceiling $112,685.50, extending through August 4, 2027) covers maintenance and repair of four Milli-Q water purification systems used by USDA's Technology and Science Division. Additionally, EMD Millipore holds positions on the Federal Supply Schedule GS24F1338C, which has generated 949 task orders worth $4.9 million combined potential value—the single largest vehicle driver—and on related GSA schedules including GS00F6165A. Task orders across these vehicles reflect routine procurement of water purification systems, assay consumables, and maintenance services.

Activity trajectory is stable but declining modestly in recent years. Awards per year declined from 63 in 2022 to 25 in 2026 (year-to-date through late October), reflecting a seasonal and cyclical procurement pattern common in federal laboratory supply markets. Twenty-three awards with ultimate completion dates in the next twenty-four months carry combined potential value of $3.1 million and represent routine recompete exposure in maintenance, service, and consumable replenishment contracts.

EMD Millipore's subcontractor footprint is minimal. Five sub-awards appear in the source: a subcontract under Fluor Marine Propulsion, LLC (February 2026) for Naval Nuclear Laboratory and Naval Nuclear Propulsion Program support involving Milli-Q systems; an xMAP analysis system subcontract under an unnamed prime (August 2025) for human health and performance research; and a cytokine assay subcontract under an unnamed prime (April 2025). A federal grant sub-award records EMD Millipore as a recipient under the University of Delaware (November 2021, CFDA not specified) for development of a CHO-based upstream process for rapid production of coronavirus antigen variants—the only grant sub-award in the source data.

EMD Millipore competes full-and-open across all named awards with no socioeconomic set-aside designations. The company does not hold 8(a), HUBZone, SDVOSB, WOSB, or other SBA certifications in the source. Corporate structure places EMD Millipore as a child entity of Cerilliant Corporation (UEI JDDKSJ34EBZ7), a foreign-owned for-profit parent, though the source does not elaborate on subsidiary roles or capability distinctions within the holding company.

The federal portfolio spans 169 distinct agencies and emphasizes civilian health, research, and biodefense sectors. The National Institutes of Health system, the Food and Drug Administration, the Centers for Disease Control and Prevention, the Department of Veterans Affairs, the Department of the Army Medical Command, and the Department of Health and Human Services dominate by award count and combined potential value. Top NAICS categories are Analytical Laboratory Instrument Manufacturing (1,698 awards) and Other Electronic and Precision Equipment Repair and Maintenance (278 awards); top PSC codes are Laboratory Equipment and Supplies (2,024 awards) and Medical and Surgical Instruments, Equipment, and Supplies (490 awards). Combined potential value across all 4,993 prime and sub awards totals $297.4 million, with $223.8 million (75 percent) obligated to date, signaling a mature federal supplier with sustained invoiced revenue depth and long-standing agency relationships rooted in proprietary water purification technology and laboratory consumable manufacturing.